RAGHAV MAHOBE
Novavax lays off 25% of workforce, releases 2023 outlookBiotech firm Novavax is reducing its global workforce by 25% as it pushes ahead with cost-cutting measures aimed at dealing with sluggish d...
Boston Scientific to buy Apollo Endosurgery for $417 millionThe offer of $10 per share in cash for Apollo Endosurgery represents a premium of nearly 67% to the stock's last close. Its shares were up ...
Moderna close to US deal to make vaccines for Ebola, biological threats: ReportThe potential deal with the U.S. Department of Defense (DoD) would see Moderna's mRNA technology being used to develop a vaccine targeting ...
- Load More